Octopus Biosafety SA (OCR) Stock Statistics & Valuation Metrics

Octopus Biosafety SA has a market cap or net worth of EUR 19.45M. The enterprise value is EUR 3.30T.

Market Cap

EUR 19.45M

Enterprise Value

EUR 3.30T

Octopus Biosafety SA has 127,127,430 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

127,127,430

Owned by Insiders

―

Owned by Institutions

―

Octopus Biosafety SA’s return on equity (ROE) is 1.00 and return on invested capital (ROIC) is 576.13%.

Return on Equity (ROE)

1.00

Return on Assets (ROA)

-1.35

Return on Invested Capital (ROIC)

576.13%

Return on Capital Employed (ROCE)

1.69

Revenue Per Employee

8,718

Profits Per Employee

-109.85K

Employee Count

6

Asset Turnover

0.11

Inventory Turnover

28.05

In the last 12 months, Octopus Biosafety SA had revenue of 52.31K and earned -659.11K in profits. Earnings per share was -0.04.

Revenue

52.31K

Gross Profit

-336.29K

Operating Income

-837.48K

Pretax Income

-838.71K

Net Income

-659.11K

EBITDA

-453.69K

Earnings Per Share (EPS)

-0.04

Beta

1.86

52-Week Price Change

33.00%

50-Day Moving Average

0.13

200-Day Moving Average

0.13

Relative Strength Index (RSI)

50.50

Average Volume (3m)

16

Octopus Biosafety SA as a current ratio of 0.31, with Debt / Equity ratio of -83.36%

Current Ratio

0.31

Quick Ratio

0.30

Debt to Market Cap

0.20

Net Debt to EBITDA

-3.39

Interest Coverage Ratio

-684.78

In the past 12 months, Octopus Biosafety SA has paid -209.06K in taxes.

Income Tax

-209.06K

Effective Tax Rate

0.25

The average price target for Octopus Biosafety SA is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

0

Revenue Growth Forecast

―

EPS Growth Forecast

―